Daily Archives: October 13, 2008

FDA Announces a Drug Approval with a Press Release

On Friday, October 10, the FDA issued a press release about a new product approval.  The approval is called Rapaflo (silodosin) capsules and it is indicated for the treatment of symptoms due to benign prostatic hyperplasia (BPH), a condition also … Continue reading

Posted in FDA Policy | 1 Comment